Toll-like receptor 2 (TLR-2) haplotypes predict outcome of patients

Details for Australian Patent Application No. 2005219473 (hide)

Owner The University of British Columbia

Inventors Walley, Keith R.; Russell, James A.

Agent FB Rice

Pub. Number AU-A-2005219473

PCT Pub. Number WO2005/085274

Priority 60/549,560 04.03.04 US

Filing date 4 March 2005

Wipo publication date 15 September 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/085274 Priority application(s): WO2005/085274

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219474-Foam insulation/shading system for transparent structures

2005219472-Thrombomodulin (THBD) haplotypes predict outcome of patients